Cargando…

Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients

INTRODUCTION: Gelsolin is an actin-binding plasma protein that is part of an 'actin-scavenging' system. Studies suggest that plasma gelsolin may play a crucial role in the pathophysiology of sepsis. Little is known about the course of plasma gelsolin levels over time in patients with sever...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, HaiHong, Cheng, BaoLi, Chen, QiXing, Wu, ShuiJing, Lv, Chen, Xie, GuoHao, Jin, Yue, Fang, XiangMing
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575595/
https://www.ncbi.nlm.nih.gov/pubmed/18706105
http://dx.doi.org/10.1186/cc6988
_version_ 1782160338875056128
author Wang, HaiHong
Cheng, BaoLi
Chen, QiXing
Wu, ShuiJing
Lv, Chen
Xie, GuoHao
Jin, Yue
Fang, XiangMing
author_facet Wang, HaiHong
Cheng, BaoLi
Chen, QiXing
Wu, ShuiJing
Lv, Chen
Xie, GuoHao
Jin, Yue
Fang, XiangMing
author_sort Wang, HaiHong
collection PubMed
description INTRODUCTION: Gelsolin is an actin-binding plasma protein that is part of an 'actin-scavenging' system. Studies suggest that plasma gelsolin may play a crucial role in the pathophysiology of sepsis. Little is known about the course of plasma gelsolin levels over time in patients with severe sepsis. The aim of the study was to investigate plasma gelsolin levels in severe septic patients and to determine whether these levels predict the severity or clinical outcome of severe sepsis. METHODS: Ninety-one patients who were diagnosed with severe sepsis at admission to a surgical intensive care unit were enrolled, and admission plasma gelsolin levels were recorded. Plasma gelsolin levels were recorded daily in 23 of these patients. Daily plasma gelsolin levels were recorded in an additional 15 nonseptic critically ill patients. Fifteen volunteers served as healthy control individuals. Plasma gelsolin levels were measured using an enzyme-linked immunosorbent assay. Concentrations of IL-6, IL-10 and tumour necrosis factor (TNF)-α were also measured on intensive care unit admission. RESULTS: The admission gelsolin levels were significantly decreased in severe sepsis (20.6 ± 11.7 mg/l) compared with nonseptic critically ill patients (52.3 ± 20.3 mg/l; P < 0.001) and healthy control individuals (126.8 ± 32.0 mg/l; P < 0.001). Severe septic patients had increased IL-6 levels compared with nonseptic critically ill patients (20.0 ± 10.7 pg/ml versus 11.4 ± 13.9 pg/ml; P = 0.048), whereas no significant difference in IL-10 or TNF-α levels was observed (IL-10: 97.9 ± 181.5 pg/ml versus 47.4 ± 91.5 pg/ml, respectively [P = 0.425]; TNF-α: 14.2 ± 13.9 pg/ml versus 6.9 ± 5.3 pg/ml, respectively; P = 0.132). Survivors of severe sepsis exhibited substantial recovery of their depressed plasma gelsolin levels, whereas gelsolin levels in nonsurvivors remained at or below their depleted admission levels. CONCLUSION: Plasma gelsolin may be a valuable marker for severe sepsis. Recovery of depleted plasma gelsolin levels correlated with clinical improvement. The prognostic role of plasma gelsolin in critical illness requires further investigation in a large cohort.
format Text
id pubmed-2575595
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-25755952008-10-30 Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients Wang, HaiHong Cheng, BaoLi Chen, QiXing Wu, ShuiJing Lv, Chen Xie, GuoHao Jin, Yue Fang, XiangMing Crit Care Research INTRODUCTION: Gelsolin is an actin-binding plasma protein that is part of an 'actin-scavenging' system. Studies suggest that plasma gelsolin may play a crucial role in the pathophysiology of sepsis. Little is known about the course of plasma gelsolin levels over time in patients with severe sepsis. The aim of the study was to investigate plasma gelsolin levels in severe septic patients and to determine whether these levels predict the severity or clinical outcome of severe sepsis. METHODS: Ninety-one patients who were diagnosed with severe sepsis at admission to a surgical intensive care unit were enrolled, and admission plasma gelsolin levels were recorded. Plasma gelsolin levels were recorded daily in 23 of these patients. Daily plasma gelsolin levels were recorded in an additional 15 nonseptic critically ill patients. Fifteen volunteers served as healthy control individuals. Plasma gelsolin levels were measured using an enzyme-linked immunosorbent assay. Concentrations of IL-6, IL-10 and tumour necrosis factor (TNF)-α were also measured on intensive care unit admission. RESULTS: The admission gelsolin levels were significantly decreased in severe sepsis (20.6 ± 11.7 mg/l) compared with nonseptic critically ill patients (52.3 ± 20.3 mg/l; P < 0.001) and healthy control individuals (126.8 ± 32.0 mg/l; P < 0.001). Severe septic patients had increased IL-6 levels compared with nonseptic critically ill patients (20.0 ± 10.7 pg/ml versus 11.4 ± 13.9 pg/ml; P = 0.048), whereas no significant difference in IL-10 or TNF-α levels was observed (IL-10: 97.9 ± 181.5 pg/ml versus 47.4 ± 91.5 pg/ml, respectively [P = 0.425]; TNF-α: 14.2 ± 13.9 pg/ml versus 6.9 ± 5.3 pg/ml, respectively; P = 0.132). Survivors of severe sepsis exhibited substantial recovery of their depressed plasma gelsolin levels, whereas gelsolin levels in nonsurvivors remained at or below their depleted admission levels. CONCLUSION: Plasma gelsolin may be a valuable marker for severe sepsis. Recovery of depleted plasma gelsolin levels correlated with clinical improvement. The prognostic role of plasma gelsolin in critical illness requires further investigation in a large cohort. BioMed Central 2008 2008-08-17 /pmc/articles/PMC2575595/ /pubmed/18706105 http://dx.doi.org/10.1186/cc6988 Text en Copyright © 2008 Wang et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Wang, HaiHong
Cheng, BaoLi
Chen, QiXing
Wu, ShuiJing
Lv, Chen
Xie, GuoHao
Jin, Yue
Fang, XiangMing
Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title_full Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title_fullStr Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title_full_unstemmed Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title_short Time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
title_sort time course of plasma gelsolin concentrations during severe sepsis in critically ill surgical patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2575595/
https://www.ncbi.nlm.nih.gov/pubmed/18706105
http://dx.doi.org/10.1186/cc6988
work_keys_str_mv AT wanghaihong timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT chengbaoli timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT chenqixing timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT wushuijing timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT lvchen timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT xieguohao timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT jinyue timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients
AT fangxiangming timecourseofplasmagelsolinconcentrationsduringseveresepsisincriticallyillsurgicalpatients